SHEPHALI PATEL: Open Payments
NPI 1154870186 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 63 payments from 17 companies in 2025. Trend: 2023 $264 · 2024 $957 · 2025 $1,405
Food & beverage: $1,335Education: $70
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $257 |
| Actelion Pharmaceuticals US, Inc. | 8 | $235 |
| Merck Sharp & Dohme LLC | 9 | $207 |
| PFIZER INC. | 10 | $176 |
| BridgeBio Pharma, Inc. | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| CVRx, Inc. | 3 | $54 |
| Ionis Pharmaceuticals, Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: LEQVIO, OPSUMIT, WINREVAIR, ELIQUIS, VYNDAQEL, Attruby, VERQUVO, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
